Literature DB >> 31367611

Is Previous Transanal Endoscopic Microsurgery for Early Rectal Cancer a Risk Factor of Worse Outcome following Salvage Surgery A Case-Matched Analysis.

Audrius Dulskas1,2,3, Aivaras Atkociunas4, Alfredas Kilius1, Kestutis Petrulis1, Narimantas E Samalavicius1,3,5.   

Abstract

INTRODUCTION: Transanal endoscopic microsurgery (TEM) is a minimally invasive procedure which allows local excision of early-stage rectal cancer and can be used as an alternative treatment to radical surgery. Patients can undergo salvage total mesorectal excision (sTME) following TEM after finding of unfavourable histological features. This study aimed to compare results and possible complications of sTME following TEM and primary TME (pTME) procedures.
METHODS: Between 2010 and 2017, early sTME was performed in 9 patients at the National Cancer Institute in Vilnius, Lithuania. These patients were compared with 18 patients who underwent pTME, matched according to gender, age, cancer stage, and operative procedure. Data were obtained from the patients' charts and reviewed prospectively. We recorded the demographics, tumour specifications, treatment, operation time, postoperative results complications, and oncological outcome. Fisher's exact test and student's T test was used to compare both groups.
RESULTS: A total of 130 patients underwent TEM at our institution during the study period, of which 9 (6.92%) had to undergo sTME. The average age of the patients was 62.7 ± 7.07 years; 44.4% of the patients were male and 55.6% female. The average tumour size in the sTME group was 2.8 ± 1.05 cm (range 1.5-5) and 2.61 ± 1.36 cm (range 1-5) in the pTME group (p = 0.696). When comparing postoperative complications, statistically significant results were not found in either of the groups (p = 0.55). Operation time of pTME was significantly shorter on average, i.e. 43 min, compared to sTME (p < 0.0267). The average number of harvested lymph nodes was 12.44 ± 7.126 in the sTME and 12.5 ± 8.06 in the pTME group (p = 0.986). The circumferential resection margin (CRM) was negative in 92.6% (25/27) of specimens, while the CRM was positive in 2 cases (7.4%), both of which were from the sTME group. The average follow-up time was 22.8 months (8-80 months) for patients undergoing sTME and 19.33 months (2-88 months) for patients after pTME (p = 0.71).
CONCLUSIONS: TEM is a relatively safe method for treating patients with early rectal cancer without high-risk features. It can be used in exceptional cases with high-risk features when the patient is not fit for radical surgery.

Entities:  

Keywords:  Rectal cancer; Salvage total mesorectal excision; Total mesorectal excision; Transanal endoscopic mircrosurgery

Year:  2018        PMID: 31367611      PMCID: PMC6616047          DOI: 10.1159/000493281

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


  35 in total

1.  Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis.

Authors:  Shandra Bipat; Afina S Glas; Frederik J M Slors; Aeilko H Zwinderman; Patrick M M Bossuyt; Jaap Stoker
Journal:  Radiology       Date:  2004-07-23       Impact factor: 11.105

Review 2.  Transanal endoscopic microsurgery: a systematic review.

Authors:  Philippa F Middleton; Leanne M Sutherland; Guy J Maddern
Journal:  Dis Colon Rectum       Date:  2005-02       Impact factor: 4.585

3.  Transanal excision for low rectal cancers is curative in early-stage disease with favorable histology.

Authors:  S Blair; J D Ellenhorn
Journal:  Am Surg       Date:  2000-09       Impact factor: 0.688

4.  Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery.

Authors:  Kevin F Birbeck; Christopher P Macklin; Nicholas J Tiffin; Wendy Parsons; Michael F Dixon; Nicholas P Mapstone; Cedric R Abbott; Nigel Scott; Paul J Finan; David Johnston; Philip Quirke
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

5.  Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit.

Authors:  Iris D Nagtegaal; Corrie A M Marijnen; Elma Klein Kranenbarg; Cornelis J H van de Velde; J Han J M van Krieken
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

6.  Outcome of local excision of rectal carcinoma.

Authors:  D Gopaul; P Belliveau; T Vuong; J Trudel; C A Vasilevsky; R Corns; Philip H Gordon
Journal:  Dis Colon Rectum       Date:  2004-11       Impact factor: 4.585

7.  Immediate radical resection after local excision of rectal cancer: an oncologic compromise?

Authors:  Dieter Hahnloser; Bruce G Wolff; David W Larson; Jennifer Ping; Santhat Nivatvongs
Journal:  Dis Colon Rectum       Date:  2005-03       Impact factor: 4.585

8.  Long-term outcomes of radical surgery after gasless video endoscopic transanal excision of T1/T2 rectal cancers.

Authors:  T Nakagoe; H Ishikawa; T Sawai; T Tsuji
Journal:  Eur J Surg Oncol       Date:  2004-08       Impact factor: 4.424

Review 9.  Transanal endoscopic microsurgery.

Authors:  E J R de Graaf
Journal:  Scand J Gastroenterol Suppl       Date:  2003

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  3 in total

Review 1.  The Role of Transanal Endoscopic Surgery for Early Rectal Cancer.

Authors:  Natalie F Berger; Patricia Sylla
Journal:  Clin Colon Rectal Surg       Date:  2022-02-28

2.  Prognosis of Patients Over 60 Years Old With Early Rectal Cancer Undergoing Transanal Endoscopic Microsurgery - A Single-Center Experience.

Authors:  Mingqing Zhang; Yongdan Zhang; Haoren Jing; Lizhong Zhao; Mingyue Xu; Hui Xu; Siwei Zhu; Xipeng Zhang
Journal:  Front Oncol       Date:  2022-06-14       Impact factor: 5.738

3.  Long-term outcomes of transanal endoscopic microsurgery for clinical complete response after neoadjuvant treatment in T2-3 rectal cancer.

Authors:  Javier Ernesto Barreras González; Haslen Cáceres Lavernia; Jorge Gerardo Pereira Fraga; Solvey Quesada Lemus
Journal:  Surg Endosc       Date:  2021-07-06       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.